Results 161 to 170 of about 2,381,877 (194)
Some of the next articles are maybe not open access.
50 Studies Every Obstetrician-Gynecologist Should Know, 2021
This article provides a summary of a landmark study regarding the diagnosis of endometrial cancer. How accurate is endometrial sampling in women with endometrial carcinoma and hyperplasia?
C. Chandler, A. Olawaiye
semanticscholar +1 more source
This article provides a summary of a landmark study regarding the diagnosis of endometrial cancer. How accurate is endometrial sampling in women with endometrial carcinoma and hyperplasia?
C. Chandler, A. Olawaiye
semanticscholar +1 more source
International Journal of Gynecological Pathology, 2021
Anti-HER2 therapy has recently emerged as an effective targeted treatment approach for patients with advanced stage and recurrent endometrial serous carcinoma, resulting in significantly prolonged progression-free and overall survival when combined with ...
N. Buza
semanticscholar +1 more source
Anti-HER2 therapy has recently emerged as an effective targeted treatment approach for patients with advanced stage and recurrent endometrial serous carcinoma, resulting in significantly prolonged progression-free and overall survival when combined with ...
N. Buza
semanticscholar +1 more source
Journal of Magnetic Resonance Imaging, 2020
Lymphovascular space invasion (LVSI) of endometrial carcinoma (EMC) is one of the important prognostic factors, which is not usually visible subjectively.
Yan Luo +4 more
semanticscholar +1 more source
Lymphovascular space invasion (LVSI) of endometrial carcinoma (EMC) is one of the important prognostic factors, which is not usually visible subjectively.
Yan Luo +4 more
semanticscholar +1 more source
Journal of Pathology, 2019
TP53 mutations are considered a surrogate biomarker of the serous‐like ‘copy number high’ molecular subtype of endometrial carcinoma (EC). In ovarian carcinoma, p53 immunohistochemistry (IHC) accurately reflects mutational status with almost 100 ...
Naveena Singh +7 more
semanticscholar +1 more source
TP53 mutations are considered a surrogate biomarker of the serous‐like ‘copy number high’ molecular subtype of endometrial carcinoma (EC). In ovarian carcinoma, p53 immunohistochemistry (IHC) accurately reflects mutational status with almost 100 ...
Naveena Singh +7 more
semanticscholar +1 more source
Molecular Genetics of Endometrial Carcinoma.
Annual Review of Pathology, 2019Endometrial cancer is the most commonly diagnosed gynecologic malignancy in the United States. Endometrioid endometrial carcinomas constitute approximately 85% of newly diagnosed cases; serous carcinomas represent approximately 3-10% of diagnoses; clear ...
D. Bell, L. Ellenson
semanticscholar +1 more source
Gynecologic Oncology, 2019
BACKGROUND The current risk stratification systems used to guide management of endometrial cancer are based on irreproducible post surgical pathological information, hence the need for more reliable classification systems. Using microarray and sequencing
E. Abdulfatah +7 more
semanticscholar +1 more source
BACKGROUND The current risk stratification systems used to guide management of endometrial cancer are based on irreproducible post surgical pathological information, hence the need for more reliable classification systems. Using microarray and sequencing
E. Abdulfatah +7 more
semanticscholar +1 more source
Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups
Archives of Gynecology and Obstetrics, 2020A. Travaglino +8 more
semanticscholar +1 more source
Adding immunotherapy to chemotherapy improves survival for endometrial cancer patients
Ca-A Cancer Journal for Clinicians, 2023Mike Fillon
exaly